Referencia

Portada Febrero HepatologyHepatology. 2016 Feb;63(2):604-19. doi: 10.1002/hep.28134. Epub 2015 Oct 10

Autores

Judit López-Luque, Daniel Caballero-Díaz, Adoración Martinez-Palacián, César Roncero, Joaquim Moreno-Càceres, María García-Bravo, Esther Grueso, Almudena Fernández, Eva Crosas-Molist, María García-Álvaro, Annalisa Addante, Esther Bertran, Angela M. Valverde, Águeda González-Rodríguez, Blanca Herrera, Lluis Montoliu, Teresa Serrano, Jose-Carlos Segovia, Margarita Fernández, Emilio Ramos, Aránzazu Sánchez, Isabel Fabregat.

Resumen

Different data support a role for the epidermal growth factor receptor (EGFR) pathway during liver regeneration and hepatocarcinogenesis. However, important issues, such as the precise mechanisms mediating its actions and the unique versus redundant functions, have not been fully defined. Here, we present a novel transgenic mouse model expressing a hepatocyte-specific truncated form of human EGFR, which acts as negative dominant mutant (ΔEGFR) and allows definition of its tyrosine kinase-dependent functions. Results indicate a critical role for EGFR catalytic activity during the early stages of liver regeneration. Thus, after two-thirds partial hepatectomy, ΔEGFR livers displayed lower and delayed proliferation and lower activation of proliferative signals, which correlated with overactivation of the transforming growth factor-β pathway. Altered regenerative response was associated with amplification of cytostatic effects of transforming growth factor-β through induction of cell cycle negative regulators. Interestingly, lipid synthesis was severely inhibited in ΔEGFR livers after partial hepatectomy, revealing a new function for EGFR kinase activity as a lipid metabolism regulator in regenerating hepatocytes. In spite of these profound alterations, ΔEGFR livers were able to recover liver mass by overactivating compensatory signals, such as c-Met. Our results also indicate that EGFR catalytic activity is critical in the early preneoplastic stages of the liver because ΔEGFR mice showed a delay in the appearance of diethyl-nitrosamine-induced tumors, which correlated with decreased proliferation and delay in the diethyl-nitrosamine-induced inflammatory process. Conclusion: These studies demonstrate that EGFR catalytic activity is critical during the initial phases of both liver regeneration and carcinogenesis and provide key mechanistic insights into how this kinase acts to regulate liver pathophysiology.

Descripción

Los grupos de investigación liderados por las doctoras Isabel Fabregat (IDIBELL), y Aránzazu Sánchez (UCM), en colaboración con el CIEMAT y el CSIC, han desarrollado un modelo de ratón modificado genéticamente que permite, por primera vez, estudiar de forma específica en los hepatocitos el papel de la actividad catalítica del receptor del factor de crecimiento epidérmico (EGFR). El trabajo, publicado en la revista Hepatology, demuestra, por un lado, que la activación de la vía del EGFR es crucial durante los primeros estadios de la regeneración hepática tras una hepatectomía parcial, viéndose esta retrasada, con baja activación de señales proliferativas y predominio de los mecanismos citostáticos. Por otro lado, la vía del EGFR juega un papel muy relevante en los estadios primarios de aparición de tumores en el hígado, presentando los ratones transgénicos un retraso en la aparición de prenódulos tras la inyección del carcinógeno dietil-nitrosamina (DEN). Este efecto se correlaciona con una menor inflamación, motor de la aparición de la hepatocarcinogenesis.

 

FotoGrupos

 

REFERENCIA DEL GRUPO INVESTIGADOR

El grupo de la doctora Isabel Fabregat, actualmente ubicado en el IDIBELL, empezó en la Universidad Complutense de Madrid, estudiando los mecanismos que controlan la proliferación, diferenciación y muerte de las células del hígado durante el desarrollo y la regeneración hepática. De éste surgió el grupo de la doctora Aránzazu Sánchez, que sigue ubicado en la UCM, manteniendo ambos grupos una estrecha colaboración. Una de sus líneas de investigación se ha enfocado al estudio del papel que juega la vía del receptor del EGF (EGFR) en las células hepáticas, sobretodo en relación a la resistencia a la muerte causada por el factor de crecimiento transformante beta (TGF-β). En este contexto, se diseñó este nuevo modelo animal, que puede contribuir al esclarecimiento de la función de la vía del EGFR en la fisiología y patología del hígado.

Descárgate este artículo aquí.

¿Acabas de publicar un artículo interesante?

Manda la referencia a través de nuestro formulario.  Límite de edad 32 años. Los artículos seleccionados serán destacados como artículos del mes y participarán en el Premio al mejor artículo de jóvenes de la SEBBM, que se entregará en el congreso de la SEBBM (inscripción y alojamiento gratuitos).

Otros "Artículos del mes"

A Mammalian Target of Rapamycin-Perilipin 3 (mTORC1-Plin3) Pathway is essential to Activate Lipophagy and Protects Against Hepatosteatosis

24-09-2021

Background and Aims: NAFLD is the most common hepatic pathology in western countries and no treatment is currently available. NAFLD is characterized by the aberrant hepatocellular accumulation of fatty acids...

Leer más

NF-κB/IKK activation by small extracellular vesicles within the SASP

07-09-2021

Cellular senescence plays an important role in different biological and pathological conditions. Senescent cells communicate with their microenvironment through a plethora of soluble factors, metalloproteases and extracellular vesicles (EV). Although...

Leer más

α-Helical peptidic scaffolds to target α-synuclein toxic species with nanomolar affinity

28-07-2021

α-Synuclein aggregation is a key driver of neurodegeneration in Parkinson's disease and related syndromes. Accordingly, obtaining a molecule that targets α-synuclein toxic assemblies with high affinity is a long-pursued objective...

Leer más

Neutrophil infiltration regulates clock-gene expression to organize daily hepatic metabolism

30-06-2021

Liver metabolism follows diurnal fluctuations through the modulation of molecular clock genes. Disruption of this molecular clock can result in metabolic disease but its potential regulation by immune cells remains...

Leer más

G6PD overexpression protects from oxidative stress and age-related hearing loss

23-05-2021

Aging of the auditory system is associated with the incremental production of reactive oxygen species (ROS) and the accumulation of oxidative damage in macromolecules, which contributes to cellular malfunction, compromises...

Leer más

Renal tubule Cpt1a overexpression protects from kidney fibrosis by restoring mitochondrial homeostasis

25-04-2021

Chronic kidney disease (CKD) remains a major epidemiological, clinical, and biomedical challenge. During CKD, renal tubular epithelial cells (TECs) present a persistent inflammatory and profibrotic response. Fatty acid oxidation (FAO)...

Leer más

Astrocyte-mediated switch in spike timing-dependent plasticity during hippocampal development

29-03-2021

Presynaptic spike timing-dependent long-term depression (t-LTD) at hippocampal CA3-CA1 synapses is evident until the 3rd postnatal week in mice, disappearing during the 4th week. At more mature stages, we found...

Leer más

Ceramide chain length–dependent protein sorting into selective endoplasmic reticulum exit sites

22-02-2021

Protein sorting in the secretory pathway is crucial to maintain cellular compartmentalization and homeostasis. In addition to coat-mediated sorting, the role of lipids in driving protein sorting during secretory transport...

Leer más

Antigen retrieval and clearing for whole-organ immunofluorescence by FLASH

25-01-2021

Advances in light-sheet and confocal microscopy now allow imaging of cleared large biological tissue samples and enable the 3D appreciation of cell and protein localization in their native organ environment...

Leer más

Viral Bcl2s' transmembrane domain interact with host Bcl2 proteins to control cellular apoptosis

08-01-2021

Viral control of programmed cell death relies in part on the expression of viral analogs of the B-cell lymphoma 2 (Bcl2) protein known as viral Bcl2s (vBcl2s). vBcl2s control apoptosis...

Leer más

Socios Protectores